Sindrome Coronario Agudo - En El Hospital Central De Ips - Paraguay
Páginas: 3 (572 palabras)
Publicado: 12 de agosto de 2012
CORONARY ACUTE SYNDROME IN PATIENTS ADMITTED TO THE EMERGENCY IN THE CENTRAL HOSPYTAL OF THE SOCIAL INSTITUTE PREVISIÒN
Authors: F. Fernandez Chamorro1, C. Saldivar , L. Fatecha , M. Centurión ,J. Paredes , L. Bell , A. Villamayor , V. Marmol , J. Gonzalez , S. Aguirre .
1-10 CARDIOLOGY-CENTRAL HOSPYTAL OF THE SOCIAL INSTITUTE PREVISIÒN
Introductions: We aim to assess the main known riskfactors for coronary acute syndromes, the response and outcome to the elective therapeutics.
Objectives:1- Prevalence of Coronary Acute Syndrome in patients (pt) admitted to the Emergency Departmentclassified by sex and age. 2- To assess the therapy they received according to the type of CAS diagnosed. 3- Identify the main risk factors related to high risk non-ST elevation coronary acutesyndrome (HR Non-STECAS).
Methods: Prospective, observational study of consecutive patients admitted to the Emergency Department of the IPS Central Hospital from June 1st to December 31st, 2006. Inclusioncriteria were: confirm diagnosis of CAS and technical data sheet fulfilled by trained physicians. Exclusion criteria: Any doubts on CAS diagnosis or impossibility to collect the technical data sheet.Statistical analyses were perform using the SPSS 13 version, software.
Results: Of 33813 patients admitted to the E.R., 2629 had cardiac diseases, 266 of them were diagnosed of CAS and 24 wereexcluded according to exclusion criteria. Thus, 242 patients was the study population.
Classified by sex: male/female M/F 123(50,8%)/119(49,2%) p: ns. Subgroup: ST-ECAS 55pt, M/F 37(67,2%)/18(32,8%) p:0,005, RR 1,99.; HR nomSTECAS 124 pt, M/F 62/62, LR nomSTECAS 63 pt, M/F 24(38%)/39(62%) p: 0,01, RR 0,6.
Classified by age: M/F 66,2 ±13,3/67,1 ±12,2; ST-ECAS M/F 69±12,5/67±12,5; HR nomSTECAS: M/F68±12,3/68±11,7; LR nomSTECAS M/F 69 ± 12,5/66 ± 13,1.
Administered therapy: Drug therapy: ST-ECAS Enoxaparine 100%, Atorvastatin 100%, AAS 96,3%, Clopidogrel 91%. HR nomSTECAS: Enoxaparine 99%,...
Authors: F. Fernandez Chamorro1, C. Saldivar , L. Fatecha , M. Centurión ,J. Paredes , L. Bell , A. Villamayor , V. Marmol , J. Gonzalez , S. Aguirre .
1-10 CARDIOLOGY-CENTRAL HOSPYTAL OF THE SOCIAL INSTITUTE PREVISIÒN
Introductions: We aim to assess the main known riskfactors for coronary acute syndromes, the response and outcome to the elective therapeutics.
Objectives:1- Prevalence of Coronary Acute Syndrome in patients (pt) admitted to the Emergency Departmentclassified by sex and age. 2- To assess the therapy they received according to the type of CAS diagnosed. 3- Identify the main risk factors related to high risk non-ST elevation coronary acutesyndrome (HR Non-STECAS).
Methods: Prospective, observational study of consecutive patients admitted to the Emergency Department of the IPS Central Hospital from June 1st to December 31st, 2006. Inclusioncriteria were: confirm diagnosis of CAS and technical data sheet fulfilled by trained physicians. Exclusion criteria: Any doubts on CAS diagnosis or impossibility to collect the technical data sheet.Statistical analyses were perform using the SPSS 13 version, software.
Results: Of 33813 patients admitted to the E.R., 2629 had cardiac diseases, 266 of them were diagnosed of CAS and 24 wereexcluded according to exclusion criteria. Thus, 242 patients was the study population.
Classified by sex: male/female M/F 123(50,8%)/119(49,2%) p: ns. Subgroup: ST-ECAS 55pt, M/F 37(67,2%)/18(32,8%) p:0,005, RR 1,99.; HR nomSTECAS 124 pt, M/F 62/62, LR nomSTECAS 63 pt, M/F 24(38%)/39(62%) p: 0,01, RR 0,6.
Classified by age: M/F 66,2 ±13,3/67,1 ±12,2; ST-ECAS M/F 69±12,5/67±12,5; HR nomSTECAS: M/F68±12,3/68±11,7; LR nomSTECAS M/F 69 ± 12,5/66 ± 13,1.
Administered therapy: Drug therapy: ST-ECAS Enoxaparine 100%, Atorvastatin 100%, AAS 96,3%, Clopidogrel 91%. HR nomSTECAS: Enoxaparine 99%,...
Leer documento completo
Regístrate para leer el documento completo.